Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Prioritize clinics prescribing FDA-approved branded medications over compounded alternatives, as these offer strong clinical trial backing and manufacturing standards
Rodent models demonstrated significant reductions in body weight and food intake via triple-receptor activation (Coskun et al., 2022) Animal studies showed improved glycemic control and lipid metabolism markers (Eli Lilly preclinical data, 2022) Mouse models observed enhanced energy expenditure compared to single- and dual-agonist controls Shipping & returns Processed within 12 business days
The company also promised to manufacture the drug in the U.S.
It is part of a class of drugs called GLP-1 receptor agonists, which work by mimicking a hormone in the body that helps regulate blood sugar levels
Who the top API suppliers in India are
US$ 25.32
US$ 25.64
US$ 21.47
